Compare DexCom, Inc. (DXCM) vs Global X Robo Global Robotics & Automation ETF (ROBO) Price & Performance

DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.

The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.

ROBO Global Robotics and Automation Index ETF trades at $79.42, down 1.68% with bearish technical signals from moving averages. The ETF provides diversified exposure to robotics and AI infrastructure stocks across 79 holdings, with recent rebalancing emphasizing physical AI and automation themes. Current technical indicators show neutral oscillators but bearish momentum signals, with key support at $79 and resistance at $81-82 levels.

The ETF's outlook balances strong thematic growth potential in robotics and AI infrastructure against cyclical exposure and valuation concerns. Key opportunities include the shift toward physical AI and global reshoring trends, while risks involve sector concentration and market volatility. Analyst sentiment remains cautiously optimistic given the long-term automation growth story.